Giuliana Farina - Concepedia

Author

Giuliana Farina

Istituti di Ricovero e Cura a Carattere Scientifico

Also Known As

Farina, Georgiy, G Farina, G. FARINA, G. Farina, Giuliana Farina

Publications

753

Citations

H-Index

Concepts

All Affiliations

Istituti di Ricovero e Cura a Carattere Scientifico Ospedale A. Perrino Ospedale Sant'Anna Fondazione IRCCS Istituto Nazionale dei Tumori Centro di Riferimento Oncologico della Basilicata

About

Giuliana Farina is an author at Istituti di Ricovero e Cura a Carattere Scientifico specializing in medicine, pathology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	423
2	Gastroenterology	2	2	25
3	Health Sciences	1	1	94
4	Public Health	1	1	24
5	Epidemiology	1	1	24

Giuliana Farina

Publications

511

Citations

H-Index

Page 1

	Year	Citations
Incidence of the JAK2 V617F mutation among patients with splanchnic or cerebral venous thrombosis and without overt chronic myeloproliferative disorders Valerio De Stefano, Alessia Fiorini, Elena Rossi, Journal of Thrombosis and Haemostasis Hematological MalignancyThrombosisGenetic DisorderJak2 V617f MutationHematology	2007	202
Second-line chemotherapy in malignant pleural mesothelioma: Results of a retrospective multicenter survey Paolo Andrea Zucali, Matteo Simonelli, G. Michetti, Lung Cancer Surgical OncologyMalignant Pleural MesotheliomaHealth SciencesMedicineRetrospective Multicenter Survey	2011	94
Methylenetetrahydrofolate reductase genotypes do not play a role in acute lymphoblastic leukemia pathogenesis in the Italian population. Patrizia Chiusolo, Giovanni Reddiconto, Giuseppe Cimino, PubMed	2004	60
MTHFR polymorphisms’ influence on outcome and toxicity in acute lymphoblastic leukemia patients Patrizia Chiusolo, Giovanni Reddiconto, Giuliana Farina, Leukemia Research Hematological MalignancyOncologyHematologyGenetic EpidemiologyPathology	2007	56
Prevalence of hepatitis A virus infection in sewage plant workers of Central Italy: is indication for vaccination justified? Paolo Bonanni, Nicola Comodo, R. Pasqui, Vaccine VaccinationCentral ItalyHepatologyViral HepatitisHealthcare-associated Infection	2000	24
Analysis of MTHFR polymorphisms and P16 methylation and their correlation with clinical–biological features of multiple myeloma Patrizia Chiusolo, Giuliana Farina, Rossana Putzulu, Annals of Hematology Mthfr PolymorphismsTumor BiologyHematological MalignancyMedicineGenetics	2006	22
Oxaliplatin plus fluoropyrimidines as adjuvant therapy for colon cancer in older patients: A subgroup analysis from the TOSCA trial Gerardo Rosati, Sara Lonardi, Fabio Galli, European Journal of Cancer Tosca TrialOncologyGastrointestinal OncologyGastroenterologyPathology	2021	15
Elotuzumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended 3‐year follow‐up of a multicenter, retrospective clinical experience with 319 cases outside of controlled clinical trials Antonella Bruzzese, Daniele Derudas, Mónica Galli, Hematological Oncology	2022	14
Carfilzomib combined with lenalidomide and dexamethasone (KRd) as salvage therapy for multiple myeloma patients: italian, multicenter, retrospective clinical experience with 600 cases outside of controlled clinical trials Enrica Antonia Martino, Concetta Conticello, Elena Zamagni, Hematological Oncology	2022	14
Etoposide, doxorubicin and cisplatin (EAP) treatment in advanced gastric carcinoma: a multicentre study of the Italian Trials in Medical Oncology (I.T.M.O.) Group Emilio Bajetta, Maria Di Bartolomeo, Filippo de Braud, European Journal of Cancer Italian TrialsGastrointestinal OncologyMedicineGastroenterologyPathology	1994	10

Page 1